×
About 255 results

ALLMedicine™ Secondary Prevention of Coronary Artery Disease Center

Research & Reviews  123 results

Canakinumab for secondary prevention of coronary artery disease.
https://doi.org/10.2217/fca-2020-0211
Future Cardiology; Ortega-Paz L, Capodanno D et. al.

Feb 3rd, 2021 - Cardiovascular disease manifestations (CVD) are the world's leading cause of death, and their impact on morbidity requires effective prevention strategies of recurrent adverse events. For decades, inflammation has been proposed as a key promoter f...

Tea consumption and its effects on primary and secondary prevention of coronary artery ...
https://doi.org/10.1016/j.clnesp.2020.11.006
Clinical Nutrition ESPEN; Dludla PV, Nkambule BB et. al.

Jan 25th, 2021 - There is a general interest in understanding how the consumption of tea impacts cardiovascular function in individuals at risk of developing cardiovascular disease (CVD). The current review focuses on evidence from randomized controlled trials (RC...

Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary ...
https://doi.org/10.1016/j.amjcard.2020.10.043
The American Journal of Cardiology; Xia M, Yang X et. al.

Nov 2nd, 2020 - Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the efficacy and safety of colchicine in patients with coronary arter...

Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE s...
https://doi.org/10.5603/CJ.a2020.0072
Cardiology Journal; Jankowski P, Kosior DA et. al.

May 21st, 2020 - The highest priority in preventive cardiology is given to patients with established coronary artery disease (CAD). The aim of the study was to assess the current implementation of the guidelines for secondary prevention in everyday clinical practi...

Outcomes of lipid control in secondary prevention of coronary artery disease in Finland...
https://doi.org/10.1016/j.atherosclerosis.2020.01.018
Atherosclerosis Leskelä RL, Torvinen A et. al.

Jan 30th, 2020 - Ischemic heart diseases are the main cause of death worldwide, therefore secondary prevention and treatment of coronary artery disease (CAD) are highly significant for public health and mortality. The objective of this study is to evaluate LDL cho...

see more →

Guidelines  3 results

Brief recommendations for participation in leisure time or competitive sports in athlet...
https://doi.org/10.1177/2047487319876186
European Journal of Preventive Cardiology; Borjesson M, Dellborg M et. al.

Sep 13th, 2019 - This paper presents a brief summary of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology (EAPC) on sports-participation in patients with coronary artery disease, coronary artery anomalies o...

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart ...
https://www.ahajournals.org/doi/abs/10.1161/ATV.0000000000000073
Newman, C.

Dec 9th, 2018 - One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cho.

The primary and secondary prevention of coronary artery disease: American College of Ch...
https://doi.org/10.1378/chest.08-0685
Chest Becker RC, Meade TW et. al.

Jul 23rd, 2008 - The following chapter devoted to antithrombotic therapy for chronic coronary artery disease (CAD) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition...

see more →

Clinicaltrials.gov  127 results

Canakinumab for secondary prevention of coronary artery disease.
https://doi.org/10.2217/fca-2020-0211
Future Cardiology; Ortega-Paz L, Capodanno D et. al.

Feb 3rd, 2021 - Cardiovascular disease manifestations (CVD) are the world's leading cause of death, and their impact on morbidity requires effective prevention strategies of recurrent adverse events. For decades, inflammation has been proposed as a key promoter f...

Tea consumption and its effects on primary and secondary prevention of coronary artery ...
https://doi.org/10.1016/j.clnesp.2020.11.006
Clinical Nutrition ESPEN; Dludla PV, Nkambule BB et. al.

Jan 25th, 2021 - There is a general interest in understanding how the consumption of tea impacts cardiovascular function in individuals at risk of developing cardiovascular disease (CVD). The current review focuses on evidence from randomized controlled trials (RC...

Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary ...
https://doi.org/10.1016/j.amjcard.2020.10.043
The American Journal of Cardiology; Xia M, Yang X et. al.

Nov 2nd, 2020 - Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the efficacy and safety of colchicine in patients with coronary arter...

Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE s...
https://doi.org/10.5603/CJ.a2020.0072
Cardiology Journal; Jankowski P, Kosior DA et. al.

May 21st, 2020 - The highest priority in preventive cardiology is given to patients with established coronary artery disease (CAD). The aim of the study was to assess the current implementation of the guidelines for secondary prevention in everyday clinical practi...

Outcomes of lipid control in secondary prevention of coronary artery disease in Finland...
https://doi.org/10.1016/j.atherosclerosis.2020.01.018
Atherosclerosis Leskelä RL, Torvinen A et. al.

Jan 30th, 2020 - Ischemic heart diseases are the main cause of death worldwide, therefore secondary prevention and treatment of coronary artery disease (CAD) are highly significant for public health and mortality. The objective of this study is to evaluate LDL cho...

see more →

News  2 results

Sticking to Meds for Heart Disease Pays Dividends
https://www.medpagetoday.com/cardiology/atherosclerosis/38117

Mar 27th, 2013 - Action Points Note that this systematic review demonstrated improved costs and outcomes among adherent patients in studies of primary or secondary prevention of coronary artery disease. Be aware that few studies contained an adequate control group...

Quality Guidelines Issued for Ambulatory Cardiac Care
https://www.mdedge.com/content/quality-guidelines-issued-ambulatory-cardiac-care-0
Alicia Ault

Jun 13th, 2011 - A group of professional societies on June 13 has issued the first set of quality improvement measures that focus on primary and secondary prevention of coronary artery disease and hypertension in the ambulatory setting. The 10 measures were charac.

see more →